Rugby Omeprazole Tablet, Delayed Release
Product Images NDC 0536-1448

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Rugby Omeprazole (NDC 0536-1448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rugby-omeprazole-carton-image.jpg (Rugby Omeprazole Carton Image)

Rugby-omeprazole-carton-image.jpg (Rugby Omeprazole Carton Image)
The text provides detailed drug facts and directions for an acid reducer medication in tablet form (Omeprazole 20mg). It includes information on how to use the product, potential side effects, warnings, and instructions for managing heartburn. The medication is meant to treat frequent heartburn and should not be used for immediate relief. It also mentions safety features, inactive ingredients, and contact information for questions or comments. Additionally, there are directions for adults 18 years and older, precautions for pregnant or breastfeeding individuals, as well as guidance on repeating courses of treatment. It also highlights when to seek medical help in case of an overdose or adverse reactions. The product is distributed by Rugby Laboratories and is manufactured in Israel.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.